Wednesday, July 8, 2026

pharma · Multiple System Atrophy · ATHE

ALTERITY THERAPEUTICS

ALTERITY THERAPEUTICS drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Melbourne, AU HQ
15 Employees
Public company Type
ATHE · NYSE Ticker
Company details
Status
Public
HQ
Melbourne, AU
Employees
15
Programs
3
Drugs
1
Patents
4
Intelligence · Drug Pipeline

ALTERITY THERAPEUTICS pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

ALTERITY THERAPEUTICS drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. Development asset linked to ALTERITY THERAPEUTICS in public FDA and regional records.